These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9247157)

  • 1. The propeptide of subtilisin BPN' as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity.
    Kojima S; Minagawa T; Miura K
    FEBS Lett; 1997 Jul; 411(1):128-32. PubMed ID: 9247157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary structure formation in the propeptide of subtilisin BPN' by successive amino acid replacements and its close relation to function.
    Kojima S; Minagawa T; Miura K
    J Mol Biol; 1998 Apr; 277(5):1007-13. PubMed ID: 9571018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated refolding of subtilisin BPN' by tertiary-structure-forming mutants of its propeptide.
    Kojima S; Yanai H; Miura K
    J Biochem; 2001 Oct; 130(4):471-4. PubMed ID: 11574065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor-assisted refolding of protease: a protease inhibitor as an intramolecular chaperone.
    Kojima S; Iwahara A; Yanai H
    FEBS Lett; 2005 Aug; 579(20):4430-6. PubMed ID: 16061231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of the propeptide of subtilisin E as an intramolecular chaperone for protein folding. Refolding and inhibitory abilities of propeptide mutants.
    Li Y; Hu Z; Jordan F; Inouye M
    J Biol Chem; 1995 Oct; 270(42):25127-32. PubMed ID: 7559646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel protease inhibitors via computational redesign of subtilisin BPN' propeptide.
    Daugherty AB; Muthu P; Lutz S
    Biochemistry; 2012 Oct; 51(41):8247-55. PubMed ID: 23009354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the C-terminal region of yeast proteinase B inhibitor 2 in its inhibitory action.
    Kojima S; Deguchi M; Miura K
    J Mol Biol; 1999 Feb; 286(3):775-85. PubMed ID: 10024450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel peptide inhibitor of subtilisin BPN'.
    Ishida K; Shimizu M; Wakasugi A; Matsui Y; Nakamura A; Kojima S
    FEBS Open Bio; 2022 Nov; 12(11):2057-2064. PubMed ID: 36053920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of inhibitory properties of Pleurotus ostreatus proteinase A inhibitor 1 by mutation of its C-terminal region.
    Kojima S; Hisano Y; Miura K
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1271-6. PubMed ID: 11243873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
    Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
    Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalysis of a protein folding reaction: thermodynamic and kinetic analysis of subtilisin BPN' interactions with its propeptide fragment.
    Strausberg S; Alexander P; Wang L; Schwarz F; Bryan P
    Biochemistry; 1993 Aug; 32(32):8112-9. PubMed ID: 8347611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of an autoprocessed Ser221Cys-subtilisin E-propeptide complex at 2.0 A resolution.
    Jain SC; Shinde U; Li Y; Inouye M; Berman HM
    J Mol Biol; 1998 Nov; 284(1):137-44. PubMed ID: 9811547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the propeptides of subtilisin E and aqualysin I as intramolecular chaperones.
    Takagi H; Koga M; Katsurada S; Yabuta Y; Shinde U; Inouye M; Nakamori S
    FEBS Lett; 2001 Nov; 508(2):210-4. PubMed ID: 11718717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hydrophobic amino acid substitution in Pleurotus ostreatus proteinase A inhibitor 1 on its structure and functions as protease inhibitor and intramolecular chaperone.
    Kojima S; Iwahara A; Hisano Y; Yanai H
    Protein Eng Des Sel; 2007 May; 20(5):211-7. PubMed ID: 17437962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
    Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of subtilisin BPN' and recombinant Streptomyces subtilisin inhibitors with substituted P1 site residues.
    Masuda-Momma K; Hatanaka T; Inouye K; Kanaori K; Tamura A; Akasaka K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Oct; 114(4):553-9. PubMed ID: 8276767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.